Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.

[1]  J. Burchenal,et al.  Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial. , 2005, European heart journal.

[2]  C. Vrints,et al.  Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. , 2005, International journal of cardiology.

[3]  R. Kloner,et al.  Cardiac protection during acute myocardial infarction: where do we stand in 2004? , 2004, Journal of the American College of Cardiology.

[4]  A. Schmermund,et al.  Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  F. Van de Werf,et al.  Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. , 2004, JAMA.

[6]  D. Mangano,et al.  Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. , 2004, The Annals of thoracic surgery.

[7]  G. Palomaki,et al.  Reference distributions for complement proteins C3 and C4: A comparison of a large cohort to the world's literature , 2004, Journal of clinical laboratory analysis.

[8]  P. Armstrong,et al.  Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) Trial , 2003, Circulation.

[9]  P. Armstrong,et al.  Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial , 2003, Circulation.

[10]  L. Guillou,et al.  Short- and Long-term Prognostic Value of Postoperative Cardiac Troponin I Concentration in Patients Undergoing Coronary Artery Bypass Grafting , 2003, Anesthesiology.

[11]  H. Wellens,et al.  Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. , 2002, European heart journal.

[12]  J. Steuer,et al.  Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting. , 2002, European heart journal.

[13]  S. Verma,et al.  Fundamentals of reperfusion injury for the clinical cardiologist. , 2002, Circulation.

[14]  S. Petersen,et al.  Application of C1-Esterase Inhibitor During Reperfusion of Ischemic Myocardium: Dose-Related Beneficial Versus Detrimental Effects , 2001, Circulation.

[15]  R. Lange,et al.  Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates. , 2001, Journal of cardiothoracic and vascular anesthesia.

[16]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[17]  G. Horstick,et al.  Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. , 1997, Circulation.

[18]  C. Visser,et al.  C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. , 1997, Circulation.

[19]  J. Mair,et al.  Cardiac troponin I release correlates with myocardial infarction size. , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[20]  A. M. Lefer,et al.  Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. , 1995, Circulation.

[21]  A. A. Taylor,et al.  Inflammation in the course of early myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Jennings Rb,et al.  EXPERIMENTAL ACUTE MYOCARDIAL INFARCTION; HISTOLOGIC AND HISTOCHEMICAL STUDIES OF EARLY MYOCARDIAL INFARCTS INDUCED BY TEMPORARY OR PERMANENT OCCLUSION OF A CORONARY ARTERY. , 1964 .

[23]  R. Jennings,et al.  EXPERIMENTAL ACUTE MYOCARDIAL INFARCTION; HISTOLOGIC AND HISTOCHEMICAL STUDIES OF EARLY MYOCARDIAL INFARCTS INDUCED BY TEMPORARY OR PERMANENT OCCLUSION OF A CORONARY ARTERY. , 1964, Laboratory investigation; a journal of technical methods and pathology.

[24]  Andres E. Salazah.  Experimental Myocardial Infarction: Induction of Coronary Thrombosis in the Intact Closed‐Chest Dog , 1961, Circulation research.